Glaukos Gross Margin 2014-2024 | GKOS
Current and historical gross margin for Glaukos (GKOS) over the last 10 years. The current gross profit margin for Glaukos as of March 31, 2024 is %.
| Glaukos Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-03-31 | $0.33B | $0.25B | 76.07% |
| 2023-12-31 | $0.31B | $0.24B | 76.11% |
| 2023-09-30 | $0.30B | $0.23B | 75.91% |
| 2023-06-30 | $0.30B | $0.22B | 75.68% |
| 2023-03-31 | $0.29B | $0.22B | 75.78% |
| 2022-12-31 | $0.28B | $0.21B | 75.62% |
| 2022-09-30 | $0.29B | $0.22B | 75.79% |
| 2022-06-30 | $0.29B | $0.22B | 76.47% |
| 2022-03-31 | $0.29B | $0.23B | 76.87% |
| 2021-12-31 | $0.29B | $0.23B | 76.87% |
| 2021-09-30 | $0.29B | $0.22B | 76.19% |
| 2021-06-30 | $0.28B | $0.21B | 74.65% |
| 2021-03-31 | $0.24B | $0.16B | 68.07% |
| 2020-12-31 | $0.23B | $0.13B | 59.56% |
| 2020-09-30 | $0.22B | $0.13B | 59.63% |
| 2020-06-30 | $0.21B | $0.13B | 63.21% |
| 2020-03-31 | $0.24B | $0.18B | 73.22% |
| 2019-12-31 | $0.24B | $0.20B | 83.61% |
| 2019-09-30 | $0.23B | $0.20B | 86.73% |
| 2019-06-30 | $0.21B | $0.18B | 86.73% |
| 2019-03-31 | $0.20B | $0.17B | 86.67% |
| 2018-12-31 | $0.18B | $0.16B | 86.19% |
| 2018-09-30 | $0.17B | $0.15B | 86.39% |
| 2018-06-30 | $0.17B | $0.14B | 86.67% |
| 2018-03-31 | $0.16B | $0.14B | 87.12% |
| 2017-12-31 | $0.16B | $0.14B | 87.42% |
| 2017-09-30 | $0.15B | $0.13B | 86.67% |
| 2017-06-30 | $0.14B | $0.12B | 86.43% |
| 2017-03-31 | $0.13B | $0.11B | 85.16% |
| 2016-12-31 | $0.12B | $0.10B | 85.22% |
| 2016-09-30 | $0.10B | $0.09B | 85.29% |
| 2016-06-30 | $0.09B | $0.08B | 84.62% |
| 2016-03-31 | $0.08B | $0.07B | 83.75% |
| 2015-12-31 | $0.07B | $0.06B | 81.94% |
| 2015-09-30 | $0.07B | $0.05B | 77.27% |
| 2015-06-30 | $0.06B | $0.05B | 76.27% |
| 2015-03-31 | $0.05B | $0.04B | 76.92% |
| 2014-12-31 | $0.05B | $0.03B | 75.56% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.926B | $0.315B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $226.930B | 27.22 |
| Intuitive Surgical (ISRG) | United States | $155.197B | 87.88 |
| Alcon (ALC) | Switzerland | $45.300B | 32.45 |
| DexCom (DXCM) | United States | $42.890B | 61.63 |
| IQVIA Holdings (IQV) | United States | $42.346B | 24.00 |
| IDEXX Laboratories (IDXX) | United States | $38.872B | 45.56 |
| Edwards Lifesciences (EW) | United States | $35.975B | 23.05 |
| STERIS (STE) | Ireland | $22.495B | 26.28 |
| Waters (WAT) | United States | $18.406B | 27.05 |
| Hologic (HOLX) | United States | $18.175B | 20.33 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.783B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.965B | 13.97 |
| Teleflex (TFX) | United States | $10.480B | 16.31 |
| Sysmex ADR (SSMXY) | Japan | $9.774B | 30.65 |
| Globus Medical (GMED) | United States | $9.713B | 28.47 |
| Penumbra (PEN) | United States | $7.369B | 83.74 |
| Masimo (MASI) | United States | $5.838B | 33.57 |
| TransMedics (TMDX) | United States | $4.809B | 456.22 |
| Integer Holdings (ITGR) | United States | $3.876B | 22.68 |
| PROCEPT BioRobotics (PRCT) | United States | $3.312B | 0.00 |
| Inari Medical (NARI) | United States | $3.209B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.894B | 17.19 |
| Tandem Diabetes Care (TNDM) | United States | $2.626B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.485B | 10.84 |
| Veracyte (VCYT) | United States | $1.816B | 0.00 |
| RxSight (RXST) | United States | $1.676B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.521B | 0.00 |
| Artivion (AORT) | United States | $1.145B | 109.84 |
| Pulse Biosciences (PLSE) | United States | $1.084B | 0.00 |
| Silk Road Medical (SILK) | United States | $1.065B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.052B | 20.46 |
| OPKO Health (OPK) | United States | $0.990B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.783B | 0.00 |
| Paragon 28 (FNA) | United States | $0.718B | 0.00 |
| SiBone (SIBN) | United States | $0.658B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.620B | 0.00 |
| IRadimed (IRMD) | United States | $0.598B | 33.51 |
| Mesa Laboratories (MLAB) | United States | $0.585B | 17.31 |
| Pacific Biosciences Of California (PACB) | United States | $0.519B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.486B | 0.00 |
| AxoGen (AXGN) | United States | $0.408B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.400B | 0.00 |
| Nevro (NVRO) | United States | $0.363B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.307B | 10.50 |
| AngioDynamics (ANGO) | United States | $0.301B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.242B | 0.00 |
| NeuroPace (NPCE) | United States | $0.234B | 0.00 |
| Inogen (INGN) | United States | $0.229B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.227B | 11.52 |
| ClearPoint Neuro (CLPT) | United States | $0.207B | 0.00 |
| CVRx (CVRX) | United States | $0.206B | 0.00 |
| 908 Devices (MASS) | United States | $0.191B | 0.00 |
| Accuray (ARAY) | United States | $0.186B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.177B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.174B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.147B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.114B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.104B | 21.86 |
| Spectral Diagnostics (EDTXF) | Canada | $0.103B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.084B | 0.00 |
| Hyperfine (HYPR) | United States | $0.083B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.079B | 0.00 |
| InspireMD (NSPR) | Israel | $0.074B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
| LENSAR (LNSR) | United States | $0.061B | 0.00 |
| Neuronetics (STIM) | United States | $0.057B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.042B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| DarioHealth (DRIO) | United States | $0.035B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.029B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.027B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.024B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.022B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.021B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |